A Year Out: Addressing International Impacts of the COVID-19 Pandemic
Testimony from Global Health Program
Testimony from Global Health Program

A Year Out: Addressing International Impacts of the COVID-19 Pandemic

March 18, 2021
Testimony
Testimony by CFR fellows and experts before Congress.

More on:

COVID-19

Public Health Threats and Pandemics

Pharmaceuticals and Vaccines

United States

Infectious Diseases

In his testimony before the U.S. House of Representatives Committee on Foreign Affairs, Thomas J. Bollyky provides an overview of current engagement of the United States and its allies in addressing the global inequities in vaccine distribution; the emerging circumstances that justify increased U.S. engagement in coronavirus vaccine diplomacy; and a proposal for a U.S.-led initiative to increase the capacity, transparency, and resilience of vaccine manufacturing in order to meet U.S. and global needs.

More on:

COVID-19

Public Health Threats and Pandemics

Pharmaceuticals and Vaccines

United States

Infectious Diseases

Top Stories on CFR

Trade

There was once a broad consensus in Washington that trade was a force for good—a way to connect, grow, and prosper. But today, trade has evolved into something much bigger than just the exchange of goods. It’s become a powerful tool to rewrite the rules of foreign policy, reshape how the United States is viewed by the rest of the world, and steer us toward an increasingly uncertain future. When did this change begin, and where did we go off course?  

Democratic Republic of Congo

Start-and-stop diplomacy continues against a backdrop of humanitarian disaster.